Nasdaq:US$14.67 (+1.22) | HKEX:HK$21.85 (-2.00) | AIM:£2.47 (+0.04)
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2010-11-30

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)